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05 CLINICS AND THERAPEUTICS
05.006 - PULMONARY CONSOLIDATIONS ON HIGH RESOLUTION
COMPUTED TOMOGRAPHY (HRCT): FREQUENCY AND REVERSIBILITY IN
CHRONIC PARACOCCIDIOIDOMYCOSIS
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B.5; Quagliato Jr., R.6
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Introduction and Objectives: Pulmonary parenchymal consolidation or air-space
opacity represents the replacement of alveolar air by exudates, transudate, cells, or other
substances, and is characterized on chest radiograph and high resolution computed
tomography (HRCT) scan by a homogenous increase in pulmonary parenchymal attenuation
that obscures the margins of vessels and airway walls, with or without air bronchogram, with
little or no volume loss. The radiological manifestations in chronic paracoccidioidomycosis
(PCM) are quite variable consisting mainly of interstitial opacities, air-space opacities, or a
combination of both. Pulmonary consolidations have been reported to occur in 30,1% to
71,43 % of patients who had received no treatment or treatment for three months or less.
Frequency drops when studies include patients with longer times of treatment, or patients
already treated. The aim of this study is to evaluate the frequency of consolidations in patients
with chronic PCM evaluated by HRCT in the first 30 days of treatment (active phase), and
the reversibility of these findings by comparison to HRCT obtained on post therapy follow-
up (inactive phase). Methods and Results: Thirty-three patients (31 males, 2 females) had
HRCT done in active phase of disease, and pulmonary consolidations were observed in 19
(57,5%). Ten patients had already finished treatment and had done a second HRCT, in inactive
phase of disease. Six of these 10 patients (60%) had 23 pulmonary consolidations, which
were mainly peripheral (47,8%), greater than 3 cm in maximum diameter (78,2%), presenting
air bronchograms (91,3%) and with no cavities (65,2%). Regression of lesions was observed
in all patients, and in all consolidations analyzed independently. Regression was complete in
three patients (50%) and in 20 consolidations (86,9%). Partial regression was observed in
three patients (50%) and in three consolidations (13%). Residual abnormalities most frequently
seen were interstitial thickening (86,9%), and fibrosis, presented as architectural distortion
and paracicatricial emphysema (69,5%). Conclusions: Although our study includes only a
few number of patients, the results indicate that pulmonary consolidations are probably a
sign of activity in chronic PCM, and may cause focal pulmonary fibrosis after resolution.
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Introduction and Objectives: PCM and TB association has been shown to occur from
15.09% (Rev Inst Med Trop [São Paulo], 34:107-15, 1992) to 19% (Allergol Immunopathol,
8:185-8, 1980). We have noticed several PCM patients with previous TB treatment, but without
positive sputum acid fast bacillus (AFB) or positive culture. At the same time, these patients
did not show clinical improvement with TB treatment, but improved after PCM treatment.
The aim of this study is to describe clinical, radiographic and microbiologic characteristics
of patients showing this association. Methods and Results: 167 patients from our hospital
from 1980 to 2000, diagnosed with adult chronic form of PCM were studied. From that
number, 27 (16,1%) had history of previous TB treatment, but only 14 (8.3%) showed positive
sputum AFB or positive culture. 13 (7.7%) were negative and did not showed improvement
after specific TB treatment. Conclusion: Despite the relative high frequency of that association,
due to the clinical and radiological similarities between both diseases, we showed almost
half of the cases being misdiagnosed.
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Introduction and Objectives: It is well known that residual cavities after inflammatory/
infectious lung diseases can harbor fungus infections by Aspergillus genus as a local and
limited infection called fungus ball, or mycetoma, or aspergilloma. The most common previous
disease causing aspergilloma is tuberculosis. As PCM can show lung residual lesions as
cavities, more cases of aspergilloma would be expected to occur, but references in the literature
are rare (Clin Infect Dis, 25:1474-5, 1997). The aim of this paper is to report a case of
aspergilloma in a residual cavity due to PMC. Case Report: A 41 years old smoking female
came complaining of 6 months history of shortness of breath, fatigue, productive cough,
daily fever, and weight loss of 20 kg. She had been submitted empirically to antituberculous
treatment without any improvement for 4 weeks. Thorax radiogram showed bilateral
heterogeneous infiltrate predominantly in the perihilar regions. Immunodifusion test for
paracoccidioides showed positive. Sputum smears and culture were negative for AFB and
fungi. After that she was put on trimethoprin plus sulfamethoxazole in November 2000 with
dramatic clinical improvement. In February 2004 she presented with blood tinged sputum.
Thorax HRCT at that time showed image of fungus ball in the left upper lobe. Bronchoscopy
with bronchial lavage was positive for Aspergillus fumigatus. After that she was sent to
surgeons to be submitted to lobectomy. Conclusion: Diagnosis of fungus ball is relatively
common after TB treated patients. To our knowledge this is the second case of aspergillus
ball in cavities due to paracoccidioidomycosis published in the literature.
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Purpose: To study patients with Tuberculosis (TB) and Paracoccidioidomycosis (PCM)
in order to compare racial incidence. Methods: 44 patients with TB and 44 with PCM were
classified by colour skin as white or non – white people. Afterwards, using family antecedents
they were reclassified and compared with state census of 2000 and our hospital out patients
average racial distribution. Results: The TB white people percentage (45,4%) only by colour
skin was lower than census (70,4%), hospital (80,7%) and PCM ( 72,5%).With family
antecedents the TB white people percentage was 27,2% and PCM 50%, but marked difference
continuous between both. Conclusions: Despite the difficult of racial classification in our
country by colour skin due to miscegenation, the difference between TB and PCM was
emphatic. As those patients are of similar socio – economic pattern it may suggest a genetic
explanation.
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Introduction and Objectives: PCM is a systemic mycosis that eventually have urogenital
involvement, including kidneys, ureter, bladder, prostate, spermatic duct, deferent duct,
testicles and penis (Rev.Ass.med.bras,19:463-6,1973; Rev.Inst.Med.trop. S.Paulo,24:240-
5,1982). The objective is to study urogenital PCM in patients followed in our Lung Division.
Methods and Results: Ten cases of PCM with compromised urogenital system were
diagnosed from 1972 to 2005, all of them with the presence of Paracoccidioides brasiliensis
in urine or histopathologic examination. Different clinical and pathologic presentations, as
well as diagnostic and therapeutic procedures were studied in each case. Conclusion:
Urogenital involvement is rare in PCM but one should be aware of it, aiming the correct
treatment and preventing sequelae.
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Introduction and Objective: The association between PCM and HIV infection in Latin
America, although consistently reported in the endemic areas of this mycoses is relatively
low in contrast to the higher incidence of other systemic endemic mycosis, e.g. histoplasmosis
and coccidioidomycosis. Moreover, little is known of the incidence and clinical manifestations
of PCM among the HIV infected population. The objective is to study the clinical
characteristics of 12 patients with paracoccidioidomycosis (PCM) and human
immunodeficiency virus (HIV) infection. Methods. The clinical manifestations, diagnosis,
treatment, and outcome of PCM in 12 patients infected with (HIV) attended at a University
Hospital of Mato Grosso do Sul, Brazil, were evaluated. Results. All patients were men,
mean age 36.1 years old, and eleven with had a diagnosis other than PCM as the aids-defining
illness. Lymph nodes were the organs most often involved (10 patients), oral mucous
membranes were involved in 8 patients and lung involvement, with a predominantly interstitial
infiltrate pattern, was observed in 7 patients. Six patients presented papule-nodular skin
lesions with central ulceration. Pleural involvement occurred in one patient who presented a
large pleural effusion caused by P. brasiliensis. Seven patients presented more than one
extrapulmonary organ with PCM. In most of the cases (8 patients) the diagnosis was established
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by direct microscopy of clinical specimens. All patients used trimethoprim-sulfamethoxazole
and seven patients were treated with amphotericin B. Eight patients died with progressive
PCM manifestations, with a mean survival of 11.4 months. The cases diagnosed after 1996
(n=5), the year of the introduction of High Active Antiretroviral Treatment for aids in Brazil,
showed some different characteristics, such as less dissemination, less skin involvement and
lower lethality, reflecting a better immunological status of the host. Conclusion. Our review
demonstrates that PCM, an endemic systemic mycosis in Brazil, when associated with aids,
behaves clinically as an opportunistic disease. Financial support: This work received financial
support from Department of Science and Technology of Health Ministry of Brazil (DECIT-
MS)
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Introduction:Paracoccidioidomycosis (Pb) is the deep mycosis most frequently occurring
in Latin America, with its incidence being highest in Brazil, especially the State of São Paulo,
with an estimate of 1-3/1000 habitants/year in endemic areas.The University Hospital of Ribeirão
Preto is the center with the largest number of cases of this co-infection.A tendency to
dissemination and simultaneous involvement of various organs has been observed in
immunodepressed patients. Objectives:To analyze in comparison to non-HIV-infected Pb
patients the epidemiological,clinical,laboratory,therapeutic and evolutive aspects of patients
co-infected with HIV-1 and P. brasiliensis in order to determine the peculiar characteristics of
seropositive patients. Methods:A retrospective 1:2 case-control study was conducted on all
HIV-1-positive patients co-infected with P. brasiliensis,older than 16 years,followed up at the
University Hospital of Ribeirão Preto.The controls were HIV-1-seronegative Pb patients selected
by drawing lots.Data were analyzed statistically using the Stata statistical software,version 8.
Results:A total of 159 patients with Pb were evaluated,53 of then infected with HIV-1 and 106
non-infected.HIV-infection was diagnosed on the basis of the Pb diagnosis in 43.4% of the
patients. HIV-positive patients showed major visceral involvement (p < 0.001). Skin involvement
occurred in 60.4% of the HIV-positive patients and in 38,7 % of the HIV-negative.The initial
determination of antibodies by counterimmunoelectrophoresis (CIE) was performed for 152
patients (102 of them not HIV-1 infected and 50 HIV-1 infected). In 16 cases the exam was
non-reactive (in 12 HIV-1-infected and 4 HIV-1- non infected patients). The mean CIE titer
was 498.5(2–4096) for HIV-1-infected patients and 1.393.5(1–65.536) for non-HIV-1-infected
patients.Seventy HIV-negative and 41 HIV-positive patients were submitted to anatomo-
pathological study,which was positive in 97.1% and 85% of them, respectively.The initial chest
radiography was altered in most cases in both groups (p = 0.021). Mean (+ SD) CD4 cell count
for HIV-infected patients was 93.9 + 129.0 cells/mm3 (0.76-480).The initial treatment consisted
of sulfamethoxazole/trimethoprim for 64.2% of the HIV-negative patients and for 45.3% of
the HIV-positive patients, while 22.6% of the HIV-positive patients were treated with
amphotericin.Cure occurred in 86.25% of he HIV-negative patients and in 72.7% of the HIV-
positive patients at the end of 12 months. Conclusions: This is the largest series reported thus
far of patients with HIV/paracoccidioidomycosis co-infection. Analysis of the data led us to
conclude that Pb tends to occur in a disseminated form in HIV-positive patients, who usually
have severe immunodeficiency,These data support the idea that all patients with disseminated
paracoccidioidomycosis should be tested serologically for HIV-1. The data suggest that P.
brasiliensis is opportunistic for patients with acquired immunodeficiency.
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Introduction and objectives : Paracoccidioidomycosis is systemic mycosis caused by
the dimorfic fungi Paracoccidioides brasiliensis originally described by Adolph Lutz, Brazil,
in 1908. It is the most important endemic mycosis in South America and Brazil is responsible
for eighty percent of the cases. This disease commonly affects multiples organs, although
ocular involviment is rare. Parinaud´ s Oculoglandular Syndrome is caracterized by
granulomatous conjuntivitis associated with homolateral cervical and either pre or retro
auricular lymph adenopathy. It has been associated with several different infectsciouns
diseases, especially the cat seratch disease (Bartonella henselae), but sometimes it has been
reported in granulomatous chronic infections. The objective of the report is to describe the
rare ocular involvement that occurs in the Paracoccidioidomycosis and especially the Parinaud´
s Syndrome. Methods and results: Descriptive Methodology of Report Case: Patient male,
44 years old, married, farm constructor, living in Pontes e Lacerda, Mato-Grosso. He
complained cervical lymphadenopathy which had started 2 months before and had swollen
and drained after 2 days. About a 1 week later appeared a papular lesion and nodule on the
face, thorax associated with dry cough, fever in the afternoon, progressive weight loss and
ulcer lesion on the right inferior eyelid with stipled hemorrhage on the surface. The
submentonian lymph nodes were aspirated and the viscous yellow pus was obtained which
was contained fungi Paracoccidioides brasiliensis on direct examination and culture. CT
thorax showed infiltratration like ground glass, nodules, small cavities, scars, bronquiectasis
in the bases and hilar region. A broncoscopy was carried out and revealed ulcer lesion on the
right and left bronchial lobes. The direct exam of the BAL revealed fungi Paracoccidioides
brasiliensis. The patient was given sulphametoxazol plus trimetropim with excellent clinical
results and disappearance of radiologicals lesions. Conclusion: It was concluded that
Paracoccidioides brasiliensis can cause typical Parinaud´s Oculoglandular Syndrome. The
importance is also emphasized for a systemic evaluation, as the disease is usually multifocal.
Bibliography: [1] An bras. Dermatol. vol.78: 1,22, no.2, 2003. [2] Arq bras. Oftalmol. 67:
541-3, 2004. [3] An bras. Dermatol, 79(1):69-78. jan-fev, 2004. [4] Rev. Inst. Med trop,
44(1):49-52, jan-fev, 2002. [5] An bras Dermatol, 78(2):135-150, mar-abr, 2003.
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Introduction: The current therapy against Paracoccidioidomycosis (PCM), as for other
mycosis, includes two classes of drugs, the polienes (Amphotericin B) and the azoles
(Itraconazole). The occurrence of resistant strains of fungi to these antifungal agents makes
the development of alternative therapies an urgent need. Recently, some reports have shown
that the new antifungal agent, Aureobasidin A, a cyclic nonapeptide obtained from the fungus
Aureobasidium pullulans, is active against Saccharomyces cerevisiae, Candida sp and
Aspergillus sp. The antifungal activity of Aureobasidin A is related to the Aur1 gene whose
product, the inositol phosphoryl ceramide synthase, is responsible for the sphingolipid
synthesis, an essential component of the fungus membrane (Curr. Drug. Targets 4:311-322,
2004). The identification of a partial sequence of the gene Aur1 in the transcriptome of
Paracoccidioides brasiliensis, the ethiologic agent of PCM, has stimulated the present
experiment [J. Biol. Chem. 280(26):24706-24714, 2005]. Objective: The aim of this project
was to evaluate the in vitro activity of Aureobasidin A against two isolates of P. brasiliensis,
Pb01 and Pb18. Antifungal activity of Aureobasidin A was compared to those obtained with
Amphotericin B and Itraconazole. Method: Aureobasidin A, Amphotericin B and Itraconazole
were tested in different concentrations (ranging from 0,0156 to 64µg.mL-1) against two strains
of P. brasiliensis, Pb01 and Pb18. These microdilution tests were performed in RPMI 1640
medium enriched with glucose 2% as suggested in the NCCLS M27A protocol. Results:
The Minimum Inhibitory Concentration (MIC) obtained for Aureobasidin A was 1µg/mL
for Pb01 and 2µg/mL for Pb18 when observed with 8 days after the beginning of the
experiment. Observations made after 18 days showed MIC of 0,5µg/mL and >64µg/mL for
Pb01 and Pb18 respectively. Conclusion: The results indicate that Aureobasidin A presents
antifungal activity against two isolates of Pb (01 and 18) when observed 8 days after the
beginning of the experiment. At longer periods of observation, the antifungal activity was
still observed for Pb01 but lower for Pb18. One possible explanation to this difference on
Aureobasidin A activity could be accounted to previous observation of the genetic variability
among P. brasiliensis isolates. As the Aur1 gene is absent in humans, it can be considered an
interesting target to the development of new therapeutic strategies against P. brasiliensis.
Complementary studies are necessary to evaluate the in vivo activity of Aureobasidin A.
Financial support: MCT, CNPq, FAP-DF.
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Introduction and Objectives: In primary or secondary bone marrow involvement from
any disease, peripheral blood (PB) can reveal “clues” that indicate a cyto-histological study
of this tissue. The aim of this study is to analyse PB parameters of paracoccidioidomycosis
(PCM) patients that can suggest infiltrative myelopathy. Methods and Results: It was achieved
a retrospective evaluation of PB data from 19 PCM patients, whose bone marrow involvement
was diagnosed in life or necropsy, at the Botucatu University Hospital. Literature review was
performed identifying 20 additional cases. Isolated or combined cytopenias (except isolated
monocytopenias or anemias) and leucoerythroblastic reaction (LER) were considered
indicative findings for bone marrow study. The main findings were: anemia (35/37; 94.6%),
normal hemoglobin value (2/37; 5.4%); leucopenia (2/38; 5.3%), leucocytosis (16/38; 42.1%),
normal leucocyte count (20/38; 52.6%); neutropenia (2/30; 6.7%), neutrophilia (13/30;
43.3%), normal neutrophil count (15/30; 50.0%); eosinophilia (21/34; 61.8%), normal
eosinophil count (13/34; 38.2%); basophilia (5/30; 16.7%), normal basophil count (25/30;
83.3%); lymphopenia (9/31; 29.0%), lymphocitosis (2/31; 6.5%), normal lymphocyte count
(20/31; 64.5%); monocytopenia (7/30; 23.3%), monocytosis (12/30; 40.0%), normal
monocyte count (11/30; 36.7%); thrombocytopenia (22.2%), thrombocytosis (27.8%), normal
trombocyte count (50.0%). Granulocytic left shift was verified in (28/32; 87.5%). Six patients
showed simultaneous erythroid left shift, characterizing LER, with or without cytopenias.
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Eight presented with cytopenias, characterized as lymphocytopenia in 6, lymphocytopenia
plus thrombocytopenia in 1, and pancytopenia in 1. Conclusions: The PB parameters varied
from normal to markedly altered values in one or more hematological lineages. Only 14/39
patients (35.9%) were indicated for bone marrow examination in this study exclusively by
abnormal peripheral blood parameters. Other indications should be assessed by suitable
clinical and laboratory evaluation in each case, as in those with suspected simultaneous
hematological neoplasia or with unsatisfactory response to treatment. References: Resende
LSR, Mendes RP, Bacchi MM et al. Infiltrative myelopathy by paracoccidioidomycosis.
Histopathol; 2005 (in press).
05.016 - DYSPHONIA AND LARYNGEAL SEQUELAE IN
PARACOCCIDIOIDOMYCOSIS PATIENTS. A MORPHOLOGICAL AND
PHONIATRIC STUDY
Weber, S. A. T.1; Brasolotto, A.2; Rodrigues, L.3; Marcondes-Machado, J.4; Padovani, C. R.5;
Carvalho, L. R.6; Mendes, R. P.7
1,3Faculdade de Medicina de Botucatu/UNESP - Oftalmologia, Otorrinolaringologia e Cirurgia
de Cabeça e Pescoço; 2Faculdade de Odontologia de Bauru/USP - Educação; 4,7Faculdade de
Medicina de Botucatu/UNESP - Doenças Tropicais e Diagnóstico por Imagem; 5,6Instituto de
Biociências de Botucatu/UNESP - Bioestatística
Introduction and objectives: Paracoccidioidomycosis (PCM) is a systemic disease
caused by Paracoccidioides brasiliensis and the larynx is the third most frequently involved
organ. The objectives of this study is to evaluate the morphological laryngeal findings and to
perform the first voice analysis in paracoccidioidomycosis patients with the clinical form
named sequelae. Methods and Results: In order to evaluate the persistent dysphonia and the
laryngeal lesions we studied 15 normal male subjects and 30 post-treatment PCM patients,
15 of whom with pulmonary disease and 15 with laryngeal and pulmonary involvement. All
the patients were submitted to perceptual and acoustic analysis of the voice; the 15 patients
with laryngeal involvement were also submitted to an endoscopic examination. The voice
analysis showed more severe dysphonia in the group of patients with laryngeal lesions
(p<0.01), characterized by roughness and breathness. The voices of both groups of patients
showed instability at perceptual analysis (p<0.01). Severe dysphonia, with a dysphonia index
higher than 7.0, was observed in 56% of the patients with laryngeal lesions. The program Dr.
Speech, Tiger Electronics, did not accept the voices of five patients with laryngeal lesions for
acoustic analysis, due to severe dysphonia. Jitter was elevated in five PCM patients with
laryngeal lesions. The endoscopic examination showed that 80% of the patients with
paracoccidioidal laryngeal lesions had two or more laryngeal structures involved. Vocal folds
alterations were observed in all the PCM patients with laryngeal involvement. Fibrous
thickening was the most frequent alteration of the vocal folds. Arytenoides, epiglottis and
vestibular folds were the other involved structures. Conclusion: This is the first functional
study of the laryngeal sequelae in PCM. It revealed frequent and severe dysphonia, suggesting
important social consequences.
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Introduction and Objectives: Reports on bone marrow impairment by
paracoccidioidomycosis (PCM) are rare and usually incomplete. The aims of this study are
to report 9 well-defined cases with infiltrative myelopathy by PCM, and describe the specific
bone marrow lesions. Methods and Results: A retrospective evaluation of patients with
PCM whose bone marrow involvement was diagnosed in life at Botucatu University Hospital
was performed. All nine patients had acute or subacute PCM. Paracoccidioides brasiliensis
was identified by bone marrow biopsy in all cases where Hematoxilin-Eosin (HE) and/or
Gomori-Grocott (GG) were used. Typical yeast forms were seen on the HE stained aspirated
clot in one un-biopsied case. Bone marrow lesions due to PCM varied from compact and
focal granulomas with few fungal cells, to numerous disseminated fungal cells within loose
granulomatous inflammatory reaction. In all cases lesions showed reticulin fibrosis.
Coagulation necrosis was focal in one case, and extensive in two others. Bone marrow
remnants were preserved in 7 patients and clearly impaired in two. Conclusions: This study
reinforces that PCM causes bone marrow granulomas, and that histological specimens, mainly
bone marrow biopsies, were best for demonstrating this. The different lesion patterns (size,
degree of organization, fibrosis, necrosis, impact on remnants of normal tissue) suggest a
wide spectrum of immune responses to the fungi. References: 1-BHARGAVA V and FARHI
DC. Bone Marrow Granulomas: Clinicopathologic Findings in 72 Cases and Review of the
Literature. Hematol. Pathol., v.2, p.43-50, 1988. 2- DIEBOLD J, MOLINA T, CAMILLERI-
BROËT S et al. Bone marrow manifestations of infections and systemic diseases observed in
bone marrow trephine biopsy. Histopathol., v.37, p.199-211, 2000.
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Introduction and Objectives: Bone marrow necrosis (BMN) is coagulation-type and
occurs due to ischemia (vascular compression by intramedular neoplasia, diseases that cause
intravascular fibrin deposition, septic or aseptic microembolization, sickle-cell diseases, severe
anemia, cardiocirculatory failure, etc). Bone trabeculae can be affected promoting
simultaneous osteonecrosis. Most cases of BMN are due to malignancies, 60% from primary
hematological tumours, and 30% from metastatic neoplasms. Although sepsis or disseminated
intravascular coagulation due to severe bacterial or fungal infections can cause BMN,
paracoccidioidomycosis (PCM) was not reported as an etiology in large series. The objective
of this study is to search for necrosis in bone marrow from dead patients with known PCM
involvement in this tissue. Methods and Results: A retrospective clinical and laboratory
evaluation of dead patients with PCM who had undergone necropsy at Botucatu University
Hospital was performed. Twelve patients had PCM with bone marrow involvement. Seven
had extensive BMN, including 4 with osteonecrosis. The necrotic areas were within loose
granulomatous inflammatory reaction presenting numerous Paracoccidioides brasiliensis
yeast forms. Bone marrow architecture was distorted, and tissue remnants were clearly
impaired in all 7 cases. Conclusions: Rarely, severe infections cause BMN. PCM, mainly the
acute or subacute form, can involve bone marrow in an extension sufficient to cause
this.References: 1- RANAGHAN L, MORRIS TCM, DESAI ZR et al.. Bone Marrow
Necrosis. Am. J. Hematol., v.47, p.225-228, 1994. 2- FOUCAR, K. Miscellaneous Disorders
of Bone Marrow Including Stromal and Bone Abnormalities. In: ____. Bone Marrow
Pathology. 1a ed. Chicago: ASCP Press, 1995. cap.25, p.431-474. 3-JANSSENS AM, OFFNER
FC and VAN HOVE WZ. Bone Marrow Necrosis. Cancer, v.88, p.1769-1780, 2000.
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Introduction and Objectives: The role of the lungs as the primary infection site in
PCM has not yet been proven beyond doubt as, in most cases, pulmonary manifestations are
not apparent during the early stages of the infection and also, because the source and moment
of infection with Paracoccidioides brasiliensis remain unknown. This study aimed at
determining the presence of mucosal and skin lesions prompting PCM patients to seek medical
attention and the coexistence, at time of diagnosis, of pulmonary abnormalities indicative of
a previous respiratory process in 115 patients with this disease. Patients and methods: This
is a retrospective study based on the scrutiny of 209 records of PCM patients who were
diagnosed and clinically supervised at the CIB´s Medical and Experimental Mycology Unit,
Medellín, Colombia. The initial lung X-rays films were examined and the means by which
diagnosis had been established (direct KOH, isolation in culture and/or biopsy specimens),
as well as the type of sample examined, were also determined. Demographic and clinical
data, symptoms and signs, type of radiographic abnormality at time of first consultation,
were analyzed. In all patients P. brasiliensis was seen (direct KOH, biopsies) and/or isolated
in culture. Results: A total of 140 (67%) patients were found to have mucosal or skin lesions
with 115 being examined fully on the basis of availability of all tests and absence of
concomitant tuberculosis. All patients were males, 14-75 year-old (mean 46.6) with most
(83.4%) having agriculture-related occupations. Smoking was common (74%). Most (86,9%)
patients had oral mucosal lesions and fewer nasal abnormalities (3,4%), either multiple or
single. Skin involvement was recorded in 33,9% with single lesions predominating. According
to the patients, external lesions had first been noticed in the last 3 months preceding
consultation in 25 (21,7%), had been present for 4-6 months in 40 (34,7%) and for 7 months
or more in 50 (43,7%) cases. Constitutional symptoms were recorded in 75,6% - with
hypertrophy of reticuloendothelial organs being noticed in 30 (26%) - patients. Pulmonary
symptoms were recorded in 110 (95,6%) patients with cough (68%), expectoration (63,6%)
and dyspnea (49%) predominating; signs were less apparent (22%). Radiographic
abnormalities were recorded in 86% of the patients with predominance of interstitial infiltrates
(92,9%), followed by fibrosis (35,3%); alveolar infiltrates were less common (27%). No
lung abnormalities were noticed in 16 patients but in 8 of them respiratory secretions revealed
the fungus or grew P. brasiliensis. Intensity of the pulmonary lesions increased in parallel
with the prolonged course of the external lesions and, additionally, fibrosis became
significantly important (p <0,01) in those patients with mucosal/skin lesions that had began
7 mos or more before the initial consultation suggesting that there was a correlation between
time of appearance of external lesions and progression of residual lung lesions. Conclusions:
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These data reveals that a large number of patients attending medical consultation due to skin
or mucosal lesions had concomitant pulmonary abnormalities demonstrated by compatible
lung X-rays findings (86%), respiratory symptoms (95,6%) or presence of P. brasiliensis in
pulmonary secretions (82,5%). It became apparent that these external lesions were secondary
to lung infection with pulmonary residual abnormalities increasing in frequency and severity
with a more prolonged duration of such external lesions.
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Introduction and objectives: Paracoccidioidomycosis (PCM), a subacute to chronic
systemic mycosis caused by Paracoccidioides brasiliensis. The aim of this study was to
investigate the efficacy, safety, and tolerability of voriconazole in the long-term treatment of
acute or chronic PCM, with itraconazole as control treatment. Methods: This was a
randomized, multicenter, open-label, comparative study conducted in Brazil in 2000-2002.
Subjects were randomized (2:1) to receive oral therapy with voriconazole or itraconazole
from 6 to 12 months. Satisfactory global response (incorporating clinical, mycologic,
radiologic, and serologic assessments) at end of treatment (EOT) was compared for the 2
treatment groups. Results: Fifty-three subjects received at least 1 dose of study drug: 35
received voriconazole and 18 received itraconazole. All but 4 subjects with confirmed PCM
(3 on voriconazole, 1 on itraconazole) received at least 6 months of continuous study treatment.
The response rates in these treatment-evaluable patients were 100% for both treatment groups,
and there were no relapses after 8 weeks of follow-up in either group. All subjects presented
lung involvement at baseline; 76% mucosal lesions, 53% lymphonode enlargement, 22%
laryngeal involvement and 22%, cutaneous lesions due do P. brasiliensis. One case with both
lung and CNS involvement. All subjects responded well to voriconazole.The most common
treatment-related events included abnormal vision, chromatopsia, rash, and headache in the
voriconazole group, and bradycardia, diarrhea, and headache in the itraconazole group. Two
voriconazole subjects were withdrawn prematurely, as required by the protocol, due to study
drug-related elevated alk phos and hepatic enzymes (ALT, AST, and GGT). The frequency
of liver function test abnormalities was slightly higher in subjects receiving voriconazole
compared to itraconazole, but the median changes in these parameters from baseline values
were similar between treatment groups. One voriconazole subject expired after 52 days
because of a rupture of an aortic aneurysm: an autopsy was performed and was negative for
PCM. Conclusions: This is the first study to demonstrate that voriconazole is well tolerated
and effective for the long-term treatment of PCM. References: [1] Brummer E, et al. Clin
Microbiol Rev. 1993;6:89-117. [2] Blotta MH, et al. Am J Trop Med Hyg. 1999;61:390-4. [3]
Perfect JR, et al. Clin Infect Dis. 2003;36:1122-31. [4] Almeida SM, et al. J Infect.
2004;48:193-8.
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Introduction and objective: The natural history of PCM as it is currently accepted
anticipates that the AF results from recent exposition to the yeast and the chronic form from
past exposition. As suggested by the antecedents of most patients, and common sense among
investigators, this exposition refers to persistent (not sporadic) contact with soil such as farm
working or construction activities. Surveys confirming the frequent infection of domestic
(dogs, horses) or savage (armadillos) animals that have habits of soil excavation support this
view. Our aim is to present 2 recent severe AF PCM cases with improbable exposition to the
yeast. Methods: data collection from health service records. Case reports: 1) A middle
class 16 y-old boy presented with a 1 month history of cervical adenomegaly and fever. On
admission, his was well despite the painful, huge and motion-limiting cervical nodes. A
node biopsy revealed the yeasts. No pulmonary involvement was noted. He was born and
had ever lived in Vila Mariana (downtown São Paulo city). His family had no rural houses,
and he disliked anything related to rural activities. He has never traveled to rural areas except
for 1 month before the start of the symptoms when he stayed for 2-3 hours in an area near
Sorocaba (São Paulo State) for fishing. He was successfully treated with sulfadiazine and is
now being followed in our out-patient service. 2) A 18 months boy, from a high middle class
family, presented with a history of 30 days of fever, emaciation, visceromegaly, discrete
cervical adenomegaly and cutaneous lesions. Diagnosis was made by cutaneous and bone
marrow biopsies. Lungs were normal; there was only mediatinal enlargement He was
successfully treated with Amphotericin B (15 days) followed by itraconazole. He has always
lived in a closed condominium of houses near Ribeirão Preto (São Paulo State) that has been
built 10 years before. The family denied travels to rural areas. Immunological testing of his
exclusive maid and parents revealed absence of sensitization to the fungus. Both patients
were immunologically evaluated and apparently do not have primary immunodeficiencies.
Conclusions: These patients pose a puzzle on how they have got the infection. Either
persistent/repetitive exposure is not necessary for development of a life threatening AF, or
the AF may eventually represent the continuum of a past infection, more distant than it is
currently believed. In the first case, we would expect clusters of cases (as in histoplasmosis),
which have never been reported; the second possibility presumes that the immune response
of AF patients can constrain the yeast for a certain period; however, this possibility does not
apply to our second patient, which is the youngest ever reported in the literature Financial
support: LIM-56, Fapesp
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Introduction: Paracoccidioidomycosis (PCM) is a systemic fungal infection of great
prevalence in Latin America. It occurs as an endemic disease in South America areas, being
more frequent in Brazil, Venezuela and Colombia. In Brazil, where the number of cases is
higher, they are more frequent in the states of São Paulo, Rio de Janeiro, Minas Gerais,
Paraná, Rio Grande do Sul, Goiás and Mato Grosso do Sul. This disease has less prevalence
in the north and the northeastern part of the country, especially in the northeast because of
the extremely dry and hot weather. This report exposes the importance of an epidemiological
survey of PCM in the state of Bahia, considering that the case report we are presenting
occurred in an uncommon region and the clinical presentation showed the commitment of
several organs and systems in the same individual. Case report: This report is about a male
patient of 41 years old, country worker, born and resident in Alagoinhas, state of Bahia, who
complained about chronic cough with yellow expectoration for 4 months. He was submitted
to a chest X-ray, when the hypothesis of lung tuberculosis was made and he began the specific
treatment for 1 month without success. The symptoms became worse and the patient appeared
with lesions that became ulcerations in the nose, in the oral mucous, in the posterior area of
the thorax and the right inguinal region. In addition, he showed enlargement of the lymph
nodes in the posterior cervical area and under the mandible area. The patient was an alcoholic
in the past, but stopped drinking about 4 years ago. He used to smoke, but quit 20 years ago.
He reported on a weight loss of 10 kg in a 4-month period. In the physical examination, he
showed vegetation lesions with ulcerations in the described places, in addition to enlarged
lymph nodes with fistula points. Chest X-ray showed diffuse interstitial infiltrate in the lung.
C.T. confirmed the lung images in detail, and the histopathological examination of the lymph
node material, the oral and face lesions revealed the presence of Paracoccidioides brasiliensis.
The sputum analysis also resulted positive for the fungus, configuring the diagnosis of PCM
with systemic involvement. The patient began the specific treatment with clinical and
laboratorial follow-up that pointed to good prognosis. Discussion: The PCM epidemiology
is better known and researched in southern and southeastern Brazil, while the epidemiological
features of the illness in northeastern Brazil are still uncertain. The present communication
draws our attention to the occurrence of PCM in northern Bahia. This disease in the state of
Bahia is more frequent in the south and in the Recôncavo Baiano, where the environmental
conditions are more propitious to fungal development. These are, however, incomplete data,
which deserve more investigation, because of the new cases in other uncommon regions
such as northern Bahia, as stated in this report. On the other hand, the immunological system
failures can probably explain the multiple lung, skin, mucous and lymph node manifestations
of the patient. Financial support: FUNDAÇÃO JOSÉ SILVEIRA - ANATOMIA
PATOLÓGICA.
